Clik here to view.
How Will Myriad Respond to the Next Generation of BRCA Testing?
Robert Cook-Deegan contributed to this commentary. Dr. Cook-Deegan is Director of the Center for Genome Ethics, Law & Policy at Duke University Institute for Genome Sciences and Policy’s and is...
View ArticleClik here to view.
What We Learned From The Myriad Oral Argument
Yesterday brought the long-anticipated oral argument in the Myriad gene patent litigation. After much speculation, the final panel consisted of Judges Lourie, Bryson and Moore. Following the Myriad...
View ArticleClik here to view.
Weekly Roundup: UK Insurance Genetics Moratorium Renewed & Breast Cancer...
With so many developments at the intersection of genomics and the law, there is often a variety of interesting stories that, for one reason or another, don’t find their way into a full-length posting...
View ArticleClik here to view.
DTC Genetic Testing and the FDA: is there an end in sight to the regulatory...
Editor’s Note: This was first published at Genomes Unzipped and was co-authored by Daniel MacArthur and Luke Jostins. Genomes Unzipped received 12 free kits from Lumigenix for review purposes, and Dan...
View ArticleClik here to view.
Pigs Return to Earth: Federal Circuit Reinstates Most—But Not All—of Myriad’s...
The Federal Circuit’s long-awaited decision (pdf) in Association for Molecular Pathology v. USPTO (the Myriad gene patent litigation) was issued this past Friday. As we were writing, with the economy...
View ArticleClik here to view.
ACLU and Myriad Both Seek Further Federal Circuit Review
As we suspected they might, the plaintiffs in Association for Molecular Pathology v. Myriad Genetics have filed a petition (pdf) seeking a rehearing of the recent federal Circuit decision. More...
View ArticleClik here to view.
Applying Mayo to Myriad: Latest Decision Brings No New News (Plus: Why the...
The latest chapter in the Myriad gene patent litigation was written yesterday, with the Federal Circuit issuing its much anticipated opinion (pdf) after rehearing the case following the Supreme Court’s...
View ArticleClik here to view.
Myriad Updates: Clinical Data as Trade Secrets and a Pending Certiorari Decision
Earlier this month, my colleagues John Conley, Robert Cook-Deegan, James Evans and I published a policy article in the European Journal of Human Genetics (EJHG) entitled “The next controversy in...
View ArticleClik here to view.
Supreme Court to Rule on Patentability of Human Genes
Robert Cook-Deegan contributed to this commentary. Dr. Cook-Deegan is a research professor in the Institute for Genome Sciences and Policy and the Sanford School of Public Policy at Duke University....
View ArticleClik here to view.
Undeterred by the Supreme Court, Myriad Starts Suing
As soon as the Supreme Court issued its decision in AMP v. Myriad Genetics, Myriad issued public statements saying that it had many surviving patents that would perpetuate its BRCA testing monopoly. We...
View Article
